Showing 1 - 6 results of 6 for search 'Joseph J Eron', query time: 0.02s Refine Results
  1. 1
    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vietnam

    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vie... by Minh X. Nguyen, Vivian F. Go, Adams L. Sibley, Hanna E. Huffstetler, Trang N.T. Do, Ha V. Tran, Le M. Giang, Teerada Sripaipan, William C. Miller, Joseph J. Eron, Cynthia L. Gay, Sarah E. Rutstein

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vietnam.

    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vie... by Minh X Nguyen, Vivian F Go, Adams L Sibley, Hanna E Huffstetler, Trang N T Do, Ha V Tran, Le M Giang, Teerada Sripaipan, William C Miller, Joseph J Eron, Cynthia L Gay, Sarah E Rutstein

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

    Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy. by Jennifer S Lee, Stephen R Cole, Chad J Achenbach, Dirk P Dittmer, David B Richardson, William C Miller, Christopher Mathews, Keri N Althoff, Richard D Moore, Joseph J Eron, Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study

    Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study by Richard D Moore, Kenneth Mayer, Greer Burkholder, Susan R Heckbert, Barbara N Harding, Bridget M Whitney, Robin M Nance, Heidi M Crane, W Christopher Mathews, Joseph J Eron, Peter W Hunt, Paul Volberding, Michael S Saag, Mari M Kitahata, Joseph A C Delaney

    Published 2020-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

    Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies by Rachel A. Bender Ignacio, Kara W. Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan, Mark J. Giganti, Justin Ritz, Michael Gibbs, Hervé Tchouakam Kouekam, Mark T. Esser, Eric S. Daar, Manish Choudhary, Rinki Deo, Courtney V. Fletcher, Jonathan Z. Li, Michael D. Hughes, Davey Smith, David Alain Wohl

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Life‐years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United States

    Life‐years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United States by Yann Ruffieux, John A. Joska, Raynell Lang, Chunyan Zheng, Naomi Folb, Gregory D. Kirk, Angela M. Parcesepe, Michael J. Silverberg, Sonia Napravnik, Kelly Gebo, Joseph J. Eron Jr, Brenna C. Hogan, Keri N. Althoff, Mpho Tlali, David J. Grelotti, Mona Loutfy, Peter F. Rebeiro, Mary‐Ann Davies, Matthias Egger, Gary Maartens, Andreas D. Haas

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: